Physician

Endocrinology

Dr. Almoatazbellah M. Idriss, MD


Almoatazbellah Idriss works in the field of Endocrinology. He studied medicine at Cairo University School of Medicine. He received awards:"CMS Meaningful Use Stage 1 Certification" and "Fellow (FACE)". Dr. Almoatazbellah M. Idriss is a published physician. He published 1 publication, including: 'Insulin therapy and glycemic control in hospitalized patients with diabetes during enteral nutrition therapy: a randomized controlled clinical trial.' Almoatazbellah Idriss accepts Medicare.



Publications


Schools


Procedures Preformed


Conditions Treated


Doctors Specialties


Accepted Insurances


Awards


Education


Hospital


Drug Facts


NPI NUMBER   1881649853
NPPES Provider LastName   IDRISS
NPPES Provider FirstName   ALMOATAZBELLAH
NPPES Provider ZIPCode   926304891
NPPES Provider State   CA
Specialty Description   Internal Medicine
Total Claim Count   585.0
Distinct Opioid Count   0.0
Opioid Claim Count   0.0
Percent Opioid Claims   0.0

Helpful Reviews


Give Anonymous Review


Medicare Facts


National Provider Identifier [NPI] 1881649853
Last Name Of The Provider IDRISS
First Name Of The Provider ALMOATAZBELLAH
View All

Similar Doctors


Dr. Robert Adler, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Anne L. Peters, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Mark L. Saginor, MD
This Doctor is OpenDoctor Recommended.
Dr. Amir Azarnivar, MD
This Doctor is OpenDoctor Recommended.
Dr. Wendy Sacks, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Behrouz Salehian, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Rashmi S. Mullur, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Anthony P. Heaney, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Anat Ben Shlomo, MD
This Doctor is OpenDoctor Recommended.
Dr. Johnathan Lopresti, MD


Doctor Directory | TOS | twitter | FB | Angel | blog